10-Q | 2019-09-30 | Filed 2019-11-19 |
10-Q | 2019-06-30 | Filed 2019-08-14 |
10-Q | 2019-03-31 | Filed 2019-05-15 |
10-K | 2018-12-31 | Filed 2019-04-01 |
10-Q | 2018-09-30 | Filed 2018-11-13 |
S-1 | 2018-08-02 | Public Filing |
10-Q | 2018-06-30 | Filed 2018-08-14 |
10-Q | 2018-03-31 | Filed 2018-05-21 |
10-K | 2017-12-31 | Filed 2018-04-02 |
10-Q | 2017-09-30 | Filed 2017-11-28 |
10-Q | 2017-06-30 | Filed 2017-11-22 |
10-Q | 2017-03-31 | Filed 2017-11-21 |
10-K | 2016-12-31 | Filed 2017-10-19 |
10-Q | 2016-09-30 | Filed 2017-04-05 |
10-Q | 2016-06-30 | Filed 2016-09-07 |
10-Q | 2016-03-31 | Filed 2016-05-05 |
10-K | 2015-12-31 | Filed 2017-08-04 |
10-Q | 2015-06-30 | Filed 2015-12-01 |
10-Q | 2015-06-30 | Filed 2015-12-01 |
10-Q | 2015-03-31 | Filed 2015-12-01 |
10-K | 2014-12-31 | Filed 2017-08-03 |
10-Q | 2014-09-30 | Filed 2015-11-25 |
10-Q | 2014-06-30 | Filed 2015-11-09 |
10-Q | 2014-03-31 | Filed 2015-11-04 |
10-K | 2013-12-31 | Filed 2017-03-27 |
10-Q | 2013-09-30 | Filed 2013-11-14 |
10-Q | 2013-06-30 | Filed 2013-08-14 |
10-Q | 2013-03-31 | Filed 2013-05-15 |
10-K | 2012-12-31 | Filed 2013-04-01 |
10-Q | 2012-09-30 | Filed 2012-11-14 |
10-Q | 2012-06-30 | Filed 2012-07-31 |
10-Q | 2012-03-31 | Filed 2012-05-11 |
10-K | 2011-12-31 | Filed 2012-03-30 |
10-Q | 2011-09-30 | Filed 2011-11-14 |
10-Q | 2011-06-30 | Filed 2011-08-15 |
10-Q | 2011-03-31 | Filed 2011-05-12 |
10-K | 2010-12-31 | Filed 2011-04-12 |
10-Q | 2010-09-30 | Filed 2010-11-22 |
10-Q | 2010-06-30 | Filed 2010-08-20 |
10-Q | 2010-03-31 | Filed 2010-05-24 |
10-K | 2009-12-31 | Filed 2010-05-14 |
8-K | 2020-05-20 | |
8-K | 2020-05-19 | |
8-K | 2020-03-30 | |
8-K | 2020-03-06 | |
8-K | 2020-02-28 | |
8-K | 2020-01-17 | |
8-K | 2019-12-12 | |
8-K | 2019-05-26 | |
8-K | 2019-03-14 | |
8-K | 2019-01-14 | |
8-K | 2018-12-18 | |
8-K | 2018-07-20 | |
8-K | 2018-06-11 | |
8-K | 2018-05-31 | |
8-K | 2018-03-02 | |
8-K | 2018-02-05 | |
8-K | 2018-01-31 |
Comps ($'000 TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
---|---|---|---|---|---|---|---|---|---|---|---|
11 Good Energy (ELVN) | |||||||||||
1347 Capital Corp (TFSC) | |||||||||||
1Life Healthcare (ONEM) | |||||||||||
1PM Industries (OPMZ) | |||||||||||
1st Century Bancshares (FCTY) | |||||||||||
1st Financial Services Corp (FFIS) | |||||||||||
1st United Bancorp (FUBC) | |||||||||||
2-Track Global (TTG) | |||||||||||
20 20 Global (TWGL) | |||||||||||
111 (YI) | 0% | 1,546,418 | 322,654 | 0 | 0 | 0 | 0 | -853,740 | |||
1 800 Flowers Com (FLWS) | 944,324 | 42% | 13.3 | 6% | 664,955 | 335,559 | 1,266,390 | 533,727 | 36,761 | 75,090 | 1,000,932 |
10x Genomics (TXG) | 4,804,979 | 75% | -490.3 | -2% | 572,815 | 151,367 | 61,207 | 45,727 | -9,603 | -8,887 | 4,357,180 |
12 Retech (RETC) | 0 | 32% | -0.1 | -1,385% | 1,118 | 20,421 | 625 | 199 | -15,491 | -14,800 | 966 |
1347 Property Insurance Holdings (PIH) | 33,711 | 0% | 0.4 | -5% | 164,088 | 108,405 | 18,194 | 0 | -7,969 | -8,017 | -2,855 |
21st Century Oncology Holdings (RTSX) | |||||||||||
180 Degree Capital (TURN) | |||||||||||
1847 Holdings (EFSH) | 25% | -2.4 | -15% | 18,527 | 23,194 | 27,219 | 6,699 | -2,862 | -1,433 | 3,396 | |
1895 Bancorp of Wisconsin (BCOW) | 46,152,715 | 12,508.1 | -0% | 441,187 | 382,722 | 0 | 0 | -44 | 3,689 | 46,142,359 | |
1st Constitution Bancorp (FCCY) | 164,504 | 0% | 4.4 | 1% | 1,342,565 | 1,204,038 | 490 | 0 | 13,787 | 32,503 | 143,748 |
024 Pharma (EEIG) |
Balance Sheet ($'000) | 2011-09-30 | 2011-12-31 | 2012-03-31 | 2012-06-30 | 2012-09-30 | 2012-12-31 | 2013-03-31 | 2013-06-30 | 2013-09-30 | 2013-12-31 | 2014-12-31 | 2015-12-31 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-12-31 | 2019-03-31 | 2019-06-30 |
Cash | 271 | 119 | 78 | 39 | 9 | 8 | 18 | 4 | 14 | 3 | 13 | 0 | 46 | 44 | 15 | 2 | 37 | 92 | 423 | 135 |
Accounts Receivable | 9 | 7 | 8 | 1 | 0 | 0 | 2 | 6 | 25 | 21 | 68 | |||||||||
Inventory | 1 | 6 | 5 | 0 | ||||||||||||||||
PP&E | 3,989 | 3,989 | 3,989 | 3,980 | 3,980 | 3,980 | 3,980 | 3,980 | 3,980 | 350 | 350 | 350 | ||||||||
Assets | 4,723 | 4,566 | 4,498 | 4,385 | 4,283 | 4,103 | 4,028 | 3,986 | 3,997 | 354 | 364 | 350 | 46 | 44 | 18 | 8 | 38 | 195 | 546 | 554 |
Accounts Payable | 12 | 9 | 4 | 4 | 4 | 4 | 8 | 27 | 16 | 70 | 112 | |||||||||
Long-Term Debt | 350 | 43 | 95 | |||||||||||||||||
Liabilities | 283 | 130 | 145 | 7 | 384 | 376 | 403 | 435 | 748 | 757 | 856 | 925 | 196 | 358 | 492 | 612 | 650 | 1,656 | 4,445 | 4,782 |
Stockholders' Equity | 4,440 | 4,436 | 4,353 | 4,377 | 3,899 | 3,727 | 3,625 | 3,551 | 3,249 | -403 | -492 | -575 | -150 | -314 | -474 | -604 | -612 | -1,461 | -3,899 | -4,228 |
Income Statement ($'000) | 2011-09-30 | 2011-12-31 | 2012-03-31 | 2012-06-30 | 2012-09-30 | 2012-12-31 | 2013-03-31 | 2013-06-30 | 2013-09-30 | 2013-12-31 | 2014-12-31 | 2015-12-31 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-12-31 | 2019-03-31 | 2019-06-30 |
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 6 | 8 | 21 | ||||||
Cost of Revenue | 11 | 15 | ||||||||||||||||||
Gross Profit | -3 | 6 | ||||||||||||||||||
R&D | ||||||||||||||||||||
SG&A | 222 | 169 | 173 | 153 | 93 | 76 | 87 | 66 | 27 | -27 | 160 | 158 | 130 | 124 | 348 | 304 | ||||
Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Net Income | -249 | -79 | -229 | -237 | -482 | -189 | -291 | 62 | -303 | -3,670 | 2 | -165 | -160 | -130 | -163 | -600 | -745 | |||
Cash Flow ($'000) | 2011-09-30 | 2011-12-31 | 2012-03-31 | 2012-06-30 | 2012-09-30 | 2012-12-31 | 2013-03-31 | 2013-06-30 | 2013-09-30 | 2013-12-31 | 2014-12-31 | 2015-12-31 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-12-31 | 2019-03-31 | 2019-06-30 |
Cash Operating | -149 | -146 | -131 | -413 | -130 | -64 | -33 | -316 | 250 | -6 | -52 | -41 | -77 | -557 | -772 | |||||
Cash Investing | -3 | 105 | 26 | 33 | 129 | 74 | 19 | 0 | 1 | 0 | 0 | |||||||||
Cash Financing | 0 | 0 | 66 | 350 | 327 | -262 | 50 | 12 | 112 | 889 | 484 |